この記事を読む

L858Rと19DelのTKI反応性の差は共存する変異の差?

Impact of Tumor Suppressor Gene Co-Mutations on Differential Response to EGFR TKI Therapy in EGFR L858R and Exon 19 Dele…

この記事を読む

完全切除後、EGFR遺伝子変異は中枢神経系転移再発のリスク因子か?

EGFR mutation is not a prognostic factor for CNS metastasis in curatively resected lung adenocarcinoma patients. Liu X e…

この記事を読む

ALK陽性でTPS高発現は極端に予後が悪い?

Investigation on the survival implications of PD-L1 expression status in ALK- rearranged advanced non-small cell lung ca…

この記事を読む

コロナワクチン4回目接種の効果

Protection by a Fourth Dose of BNT162b2 against Omicron in Israel. Bar-On YM et al.N Engl J Med. 2022 May 5;386(18):1712…

この記事を読む

小型肺癌に対する標準術式

Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre,…

この記事を読む

ICI臨床試験の結果は日常臨床を反映するか?

Generalizability of immune checkpoint inhibitor trials to real-world patients with advanced non-small cell lung cancer. …

この記事を読む

IMpower 150のEGFR遺伝子変異陽性群についてのupdate

IMpower150 Final Exploratory Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in Key NSCLC Patient Subgroups …

この記事を読む

ロルラチニブのbeyond投与

Continuation of Lorlatinib in ALK-Positive NSCLC Beyond Progressive Disease. Ou SI et al.J Thorac Oncol. 2022 Apr;17(4):…

この記事を読む

間質性肺炎合併肺癌の手術成績

Survival after surgery for clinical stage I non-small-cell lung cancer with interstitial pneumonia. Fukui M et al.Lung C…

この記事を読む

定位放射線治療での予後予測

Nomogram Predicting Overall Survival Benefit of Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung C…